Credit Suisse’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-1,898,904
| Closed | -$1.03M | – | 3931 |
|
|
2016
Q3 | $1.03M | Sell |
1,898,904
-237,078
| -11% | -$129K | ﹤0.01% | 2616 |
|
|
2016
Q2 | $1.24M | Buy |
2,135,982
+195,142
| +10% | +$113K | ﹤0.01% | 2476 |
|
|
2016
Q1 | $2.83M | Sell |
1,940,840
-42,842
| -2% | -$62.6K | ﹤0.01% | 1734 |
|
|
2015
Q4 | $6.35M | Sell |
1,983,682
-791,559
| -29% | -$2.53M | 0.01% | 1310 |
|
|
2015
Q3 | $17.3M | Buy |
2,775,241
+1,838,336
| +196% | +$11.5M | 0.02% | 770 |
|
|
2015
Q2 | $9.3M | Buy |
+936,905
| New | +$9.3M | 0.01% | 1180 |
|
|
2015
Q1 | – | Sell |
-18,876
| Closed | -$101K | – | 4372 |
|
|
2014
Q4 | $101K | Buy |
+18,876
| New | +$101K | ﹤0.01% | 4053 |
|
|
2014
Q2 | – | Sell |
-182,349
| Closed | -$1.32M | – | 4487 |
|
|
2014
Q1 | $1.32M | Sell |
182,349
-152,316
| -46% | -$1.1M | ﹤0.01% | 2545 |
|
|
2013
Q4 | $1.26M | Buy |
334,665
+60,349
| +22% | +$227K | ﹤0.01% | 2699 |
|
|
2013
Q3 | $922K | Buy |
274,316
+31,188
| +13% | +$105K | ﹤0.01% | 2639 |
|
|
2013
Q2 | $812K | Buy |
+243,128
| New | +$812K | ﹤0.01% | 2594 |
|